CC

CNCB Capital

Asia, Hong Kong Island, Hong Kong, Hong Kong

Description

CNCB Capital is an investment firm.

Investor Profile

CNCB Capital has made 3 investments, with 2 in the past 12 months and 33% as lead.

Stage Focus

  • Series C (33%)
  • Series D (33%)
  • Series A (33%)

Country Focus

  • China (100%)

Industry Focus

  • Biotechnology
  • Oncology
  • Pharmaceutical
  • Artificial Intelligence (Ai)
  • Big Data
  • Health Care
  • Mobile Apps
  • Industrial
  • Mining
  • Mining Technology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does CNCB Capital frequently co-invest with?

GL Ventures LLC
Asia, Beijing, China, Beijing
Co-Investments: 1
Co-Stone Venture Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
Cenova
Asia, Shanghai, China, Shanghai
Co-Investments: 1
CDH Investments
Asia, Kowloon, Hong Kong, Kowloon City
Co-Investments: 1
PC
North America, Massachusetts, United States, Natick
Co-Investments: 1
CCB International
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
Everbright
Asia, Hong Kong Island, Hong Kong, Wan Chai
Co-Investments: 1

What are some of recent deals done by CNCB Capital?

Shangshan Intelligent Gold Academy focuses on exploration and mining, design and development, processing and manufacture, etc.

IndustrialMiningMining Technology
Series AMar 10, 2025
Weimai

Yuhang, Zhejiang, China

Weimai uses big data and artificial intelligence to digitize their healthcare service platform.

Artificial Intelligence (AI)Big DataHealth CareMobile Apps
Series DJan 7, 2025
Amount Raised: $27,289,597
IASO Biotherapeutics

Nanjing, Jiangsu, China

IASO Biotherapeutics is a biopharmaceutical company focused on the development of cell therapies in the field of oncology.

BiotechnologyOncologyPharmaceutical
Series CSep 16, 2021
Amount Raised: $108,000,000